News related to Neoral (Cyclosporine) and/or conditions it is approved for
Drug and Device Approvals: Europe and Japan Source: Medscape Primary Care Headlines [2004.08.24] The EU has approved rituximab (MabThera) and duloxetine (Yentreve-Ariclaim) for use in the European Union, and orphan status for inhaled cyclosporine; Japan has approved a cobalt alloy stent (Driver Coronary Stent System). Medscape Medical News Yael Waknine